Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Nov 20, 2013

30071_dirs_2013-11-20_caa2483c-3825-404d-964a-b5f791ec1cc4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-18

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-18 ResMed Common Stock M 5429 $50.73 Acquired 59955.015 Direct

Footnotes

F1: Represents vested restricted stock units initially granted on November 16, 2011.

F2: Includes 444.873 shares purchased on April 30, 2013 through the company's Employee Stock Purchase Plan.